ARKO vs CNNE
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ARKO's Piotroski F-Score of 4/9 indicates weak financial health, signaling distress in operational efficiency and capital structure. The absence of an Altman Z-Score raises red flags for potential bankruptcy risk, especially given a dangerously high Debt/Equity ratio of 7.02. While the stock trades below its Graham Number ($2.85) and intrinsic value ($1.05), it is currently priced at $5.26—well above both, suggesting a significant premium driven by speculative growth expectations. Despite strong earnings surprises in recent quarters and a 'strong_buy' analyst consensus, the company exhibits negative revenue growth (-10.7% YoY), deteriorating profitability, and a high payout ratio of 80%, undermining sustainability. The technical trend is bearish (0/100), reinforcing downward momentum.
CNNE exhibits severe fundamental distress, highlighted by a critical Piotroski F-Score of 1/9, indicating extremely poor financial health. The company is suffering from massive profitability collapses with a profit margin of -121.15% and a consistent track record of missing earnings estimates by wide margins. While the stock trades at a discount to book value (P/B 0.60) and maintains a low debt-to-equity ratio, these are overshadowed by declining revenues and a bearish technical trend. There is a stark disconnect between the objective financial decay and the 'strong_buy' analyst consensus.
Compare Another Pair
Related Comparisons
ARKO vs CNNE: Head-to-Head Comparison
This page compares Arko Corp. (ARKO) and Cannae Holdings, Inc. (CNNE) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.